Hospital Profile
Name | Mercyone Waterloo Medical Center |
---|
Type | Acute Care Hospital |
---|
Location | 3421 West Ninth Street, Waterloo, Iowa |
---|
Ownership | Voluntary non-profit - Church |
---|
Emergency Services | Yes |
---|
Medicare ID (CCN) | 160067 |
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Mercyone Waterloo Medical Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
NPI Number | 1700827896 |
Organization Name | COVENANT MEDICAL CENTER INC |
Doing Business As | MERCYONE WATERLOO MEDICAL CENTER |
Address | 3421 W 9th St, Waterloo, IA 50702 |
Hospital Type | General Acute Care Hospital |
Phone Number | 319-272-8000 |
News Archive
Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference
Chromatrap, a business unit of Porvair Sciences, has announced that it will be the Lead Sponsor at the prestigious "Epigenetics in Drug Discovery" conference to be held in Cambridge, UK from 26th-27th January 2016.
ARYx common stock listing to be transferred to NASDAQ Capital Market
ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.
U of U Health supports Governor's decision to authorize COVID-19 booster doses for all adults in Utah
University of Utah Health supports Governor Spencer Cox's decision to authorize booster doses of COVID-19 vaccines for all people living in Utah who are aged 18 and older.
U.S. FDA orders three TMJ implant manufacturers to conduct postmarket surveillance studies
Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.
Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty
In the meta-analysis, Luoping Zhang, University of California, Berkeley, and her team pursued the question of whether people who used plant protection products containing glyphosate had an increased risk of contracting Non-Hodgkin Lymphoma, a form of lymph node cancer.
Read more Medical News
› Verified 5 days ago
Structural Quality Measures:
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference
Chromatrap, a business unit of Porvair Sciences, has announced that it will be the Lead Sponsor at the prestigious "Epigenetics in Drug Discovery" conference to be held in Cambridge, UK from 26th-27th January 2016.
ARYx common stock listing to be transferred to NASDAQ Capital Market
ARYx Therapeutics, Inc. today announced that it has been notified by The NASDAQ Stock Market ("NASDAQ") that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010.
U of U Health supports Governor's decision to authorize COVID-19 booster doses for all adults in Utah
University of Utah Health supports Governor Spencer Cox's decision to authorize booster doses of COVID-19 vaccines for all people living in Utah who are aged 18 and older.
U.S. FDA orders three TMJ implant manufacturers to conduct postmarket surveillance studies
Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or replaced due to pain or other reasons.
Meta-analysis of glyphosate-based plant protection products and NHL involves uncertainty
In the meta-analysis, Luoping Zhang, University of California, Berkeley, and her team pursued the question of whether people who used plant protection products containing glyphosate had an increased risk of contracting Non-Hodgkin Lymphoma, a form of lymph node cancer.
Read more News
› Verified 5 days ago